RVNC

Revance Therapeutics, Inc.

Delisted

RVNC was delisted on the 5th of February, 2025.

80 hedge funds and large institutions have $301M invested in Revance Therapeutics, Inc. in 2014 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 40 increasing their positions, 19 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
80
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$20.1M
2 +$5.2M
3 +$2.95M
4
AllianceBernstein
AllianceBernstein
Tennessee
+$2.74M
5
JP Morgan Chase
JP Morgan Chase
New York
+$2.23M

Top Sellers

1 -$21.4M
2 -$15.9M
3 -$12.3M
4
DM
Deerfield Management
New York
-$8.72M
5
Zurich Cantonal Bank
Zurich Cantonal Bank
Switzerland
-$4.42M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$4K
77
$3K
78
$2K
79
$1.85K
80
$109
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100